ArticlePLOS global public health2026

Cost-effectiveness of BPaL-based and 9-month modified all-oral short treatment regimens for rifampicin-resistant tuberculosis in Belarus.

Natalia YatskevichPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.